Join us for an insightful webinar discussion on the use of precision oncology and breast cancer management in the Asia-Pacific (APAC) region. This event will feature leading oncologists who will share their clinical expertise and discuss the application of Comprehensive Genomic Profiling (CGP) and Molecular Tumor Board (MTB), as well as updated breast cancer testing and treatment in APAC region:
Details
Time
16:00 - 19:30
Topics
Clinical sharing on the effective role of comprehensive genomic profiling (CGP) within molecular tumour boards (MTBs) in clinical settings
Latest developments in liquid biopsy and associated approaches in cancer care
The clinical utility of CGP across tumour types and the value of precision oncology to improve patient outcomes
Value of PIK3CA mutation testing in HR+/HER2- metastatic breast cancer
Hear from experts on their clinical experience using CGP, MTB, and their value in precision oncology
Get updates on the new biomarker and genomic signatures, and tissue-based vs liquid-based testing
Learn about upcoming PIK3CA testing and treatment in breast cancer
Speakers
Dr. Herbert Loong
Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong
Dr. Linda Mileshkin
Director of Medical Oncology, Peter MacCallum Cancer Centre, Australia
Dr. Sewanti Limaye
Director of Medical & Precision Oncology, Reliance Foundation Hospital & Research Center, India
Dr. Dejan Juric
Director, Termeer Center for Targeted Therapies & Investigational Cancer Therapeutics Program, Massachusetts General Hospital Cancer Centre, U.S.A.
Moderators
Dr. Daniel Chan
Senior Consultant, Medical Oncology, ICON Cancer Centre, Singapore
Dr. Yoon Sim Yap
Senior Consultant, Division of Medical Oncology, National Cancer Centre, Singapore
Agenda
Time
Topic
Speakers
16:00 - 16:10
Opening and Introduction
Mr. Lance Little Head of Region Asia Pacific, Roche Diagnostics Ltd.
16:10 - 16:40
Trends and Challenges in Molecular Tumour Board Implementation in Asia-Pacific Region: APAC MTB Expert Consensus Statement
Dr. Herbert Loong
16:40 - 17:10
Unlocking the Power of Liquid Biopsy-based Profiling in Clinical Practice
Dr. Linda Mileshkin
17:10 - 17:40
Panel Discussion: Facilitating Access to Molecularly Guided Treatment Options by Leveraging Advancements in Genomic Profiling and Molecular Tumour Boards
Panelists: Dr. Herbert Loong Dr. Linda Mileshkin Dr. Aya Helali
17:40 - 17:55
Break
All
17:55 - 18:25
The Evolution of Comprehensive Genomic Profiling: From Lung Cancer Pioneers to Ovarian and Breast Cancer Paradigms
Dr. Sewanti Limaye
18:25 - 18:55
Targeting PIK3CA Mutation in Breast Cancer: From Testing to Therapeutic Strategies
Dr. Dejan Juric
18:55 - 19:25
Panel Discussion: Management of Novel Genes in Breast Cancer
Panelists: Dr. Dejan Juric Dr. Sewanti Limaye Dr. Pranav Dorwal
19:25 - 19:30
Closing
Dr. Ahmed Elhusseiny Area Head APAC, Roche Pharmaceuticals
This material represents personal viewpoint and is intended to promote the communication and exchange of medical information, and shall be used by healthcare professionals as a reference only. This material may contain medicinal products or clinical indications that have not yet been approved in your country. Please refer to the locally approved package insert for detailed prescription information.
Be the first to receive updates, event opportunities, and thought leadership insights.
The information contained in this website is intended for healthcare professionals only.
Click “OK” if you are a healthcare professional.
